Chemical systems biology reveals mechanisms of glucocorticoid receptor signaling

Glucocorticoids display remarkable anti-inflammatory activity, but their use is limited by on-target adverse effects including insulin resistance and skeletal muscle atrophy. We used a chemical systems biology approach, ligand class analysis, to examine ligands designed to modulate glucocorticoid re...

Full description

Saved in:
Bibliographic Details
Published inNature chemical biology Vol. 17; no. 3; pp. 307 - 316
Main Authors Bruno, Nelson E, Nwachukwu, Jerome C, Srinivasan, Sathish, Nettles, Charles C, Izard, Tina, Jin, Zhuang, Nowak, Jason, Cameron, Michael D, Boregowda, Siddaraju V, Phinney, Donald G, Elemento, Olivier, Liu, Xu, Ortlund, Eric A, Houtman, René, Stavreva, Diana A, Hager, Gordon L, Kamenecka, Theodore M, Kojetin, Douglas J, Nettles, Kendall W
Format Journal Article
LanguageEnglish
Published United States Nature Publishing Group 01.03.2021
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Glucocorticoids display remarkable anti-inflammatory activity, but their use is limited by on-target adverse effects including insulin resistance and skeletal muscle atrophy. We used a chemical systems biology approach, ligand class analysis, to examine ligands designed to modulate glucocorticoid receptor activity through distinct structural mechanisms. These ligands displayed diverse activity profiles, providing the variance required to identify target genes and coregulator interactions that were highly predictive of their effects on myocyte glucose disposal and protein balance. Their anti-inflammatory effects were linked to glucose disposal but not muscle atrophy. This approach also predicted selective modulation in vivo, identifying compounds that were muscle-sparing or anabolic for protein balance and mitochondrial potential. Ligand class analysis defined the mechanistic links between the ligand-receptor interface and ligand-driven physiological outcomes, a general approach that can be applied to any ligand-regulated allosteric signaling system.
Bibliography:Current affiliation: Corbus Pharmaceuticals, Inc. 500 River Ridge Dr. Norwood, MA 02062.
Author contributions. N.E.B. and K.W.N. designed the research; N.E.B., K.W.N., S.V.B, J.C.N., G.L.H., M.C., R.H. designed and developed methods; N.E.B., S.S., S.V.B., J.C.N., C.C.N., J.N., D.A.S., R.H., D.J.K., X.L., O.E., Z.J., and T.M.K. performed experiments under the supervision of K.W.N., N.E.B., G.L.H., T.M.K., E.A.O., T.I.; M.D.C. performed the mouse pharmacokinetics study; Z.J., T.M.K. provided compounds; K.W.N., N.E.B., J.C.N., X.L., E.A.O., D.J.K, and E.O. wrote the manuscript.
ISSN:1552-4450
1552-4469
DOI:10.1038/s41589-020-00719-w